IL53596A - Biological cells externally modified for controlled release,in the spleen and/or liver,of pharmaceutically active substances comprised therein,their preparation and pharmaceutical compositions containing them - Google Patents

Biological cells externally modified for controlled release,in the spleen and/or liver,of pharmaceutically active substances comprised therein,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL53596A
IL53596A IL53596A IL5359677A IL53596A IL 53596 A IL53596 A IL 53596A IL 53596 A IL53596 A IL 53596A IL 5359677 A IL5359677 A IL 5359677A IL 53596 A IL53596 A IL 53596A
Authority
IL
Israel
Prior art keywords
spleen
liver
preparation
pharmaceutical compositions
controlled release
Prior art date
Application number
IL53596A
Other languages
English (en)
Other versions
IL53596A0 (en
Original Assignee
Kernforschungsanlage Juelich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kernforschungsanlage Juelich filed Critical Kernforschungsanlage Juelich
Publication of IL53596A0 publication Critical patent/IL53596A0/xx
Publication of IL53596A publication Critical patent/IL53596A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL53596A 1976-12-15 1977-12-13 Biological cells externally modified for controlled release,in the spleen and/or liver,of pharmaceutically active substances comprised therein,their preparation and pharmaceutical compositions containing them IL53596A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2656746A DE2656746C2 (de) 1976-12-15 1976-12-15 Verwendung von beladenen Erythrozyten

Publications (2)

Publication Number Publication Date
IL53596A0 IL53596A0 (en) 1978-03-10
IL53596A true IL53596A (en) 1981-06-29

Family

ID=5995573

Family Applications (1)

Application Number Title Priority Date Filing Date
IL53596A IL53596A (en) 1976-12-15 1977-12-13 Biological cells externally modified for controlled release,in the spleen and/or liver,of pharmaceutically active substances comprised therein,their preparation and pharmaceutical compositions containing them

Country Status (8)

Country Link
US (1) US4289756A (da)
JP (1) JPS5375385A (da)
CH (1) CH632928A5 (da)
DE (1) DE2656746C2 (da)
FR (1) FR2374045A1 (da)
GB (1) GB1557649A (da)
IL (1) IL53596A (da)
SE (1) SE445296B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2655801C2 (de) * 1976-12-09 1986-06-26 Kernforschungsanlage Jülich GmbH, 5170 Jülich Injizierbare Suspension von Membranvesikeln aus Erythrozyten und Verfahren zur Herstellung der Suspension
US4403038A (en) * 1979-04-11 1983-09-06 Toshio Asakura Buffered serum substitute for blood oxygen analyzer
US4358394A (en) * 1979-05-07 1982-11-09 Coulter Electronics, Inc. Process for preparing whole blood reference controls having long term stability
US4489162A (en) * 1981-12-21 1984-12-18 American Hospital Supply Corporation Fresh blood (unfixed) hematology control
FR2529463B1 (fr) * 1982-07-05 1986-01-10 Centre Nat Rech Scient Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus
US4478824A (en) * 1983-08-08 1984-10-23 Franco Robert S Method for altering red blood cell function and survival
EP0266418A4 (en) * 1986-05-09 1989-02-13 Electropore Inc DEVICE AND METHOD FOR FORMING PORES IN VESICLES, AND METHOD FOR CHARGING AND MELTING.
US4906576A (en) * 1986-05-09 1990-03-06 Electropore, Inc. High speed, high power apparatus for vesicle prealignment, poration, loading and fusion in uniform electric fields and method therefor
US4923814A (en) * 1986-05-09 1990-05-08 Electropore, Inc. High speed, high power apparatus for vesicle prealignment, poration, loading and fusion in uniform electric fields and method therefor
US4931276A (en) * 1987-10-30 1990-06-05 Franco Robert S Method for introducing desired agents into red blood cells
CA1327174C (en) * 1988-10-05 1994-02-22 Youssef Mouneimne Electro-insertion of proteins into animal cell membranes
US5236835A (en) * 1988-10-05 1993-08-17 Hapgood, C.V. Electro insertion of proteins into red cell membranes
US5443813A (en) * 1991-06-06 1995-08-22 Associated Universities, Inc. Loading and conjugating cavity biostructures
US5173158A (en) * 1991-07-22 1992-12-22 Schmukler Robert E Apparatus and methods for electroporation and electrofusion
WO1993018397A1 (en) * 1992-03-02 1993-09-16 Streck Laboratories, Inc. Reference control for use with manual and flow cytometric reticulocyte counting devices
EP0882448B1 (en) * 1997-05-05 2005-01-12 DIDECO S.r.l. Method of encapsulating biologically active agents within erythrocytes and apparatus therefor
EP1663158A2 (en) * 2003-06-24 2006-06-07 Baxter International Inc. Specific delivery of drugs to the brain
US8986736B2 (en) * 2003-06-24 2015-03-24 Baxter International Inc. Method for delivering particulate drugs to tissues
CA2554246A1 (en) * 2004-01-29 2005-08-11 Baxter International Inc. Nanosuspensions of anti-retroviral agents for increased central nervous system delivery
KR20070037444A (ko) * 2004-06-15 2007-04-04 백스터 인터내셔널 인코포레이티드 고체 미립자성 치료제의 생체외 적용방법
DE102004054536A1 (de) * 2004-11-06 2006-05-11 Capsulution Nanoscience Ag Multimodal veränderte Zellen als zellulare Darreichungsformen für aktive Substanzen und als diagnostische Zellpartikel
BRPI0909780B1 (pt) 2008-03-05 2022-05-03 Baxter International Inc Suspensão contendo uma partícula com superfície modificada, composição farmacêutica compreendendo a referida suspensão, método para aprimorar a absorção celular de um agente ativo, uso de partículas com superfície modificada, e método de preparação de uma partícula com superfície modificada
US10952965B2 (en) * 2009-05-15 2021-03-23 Baxter International Inc. Compositions and methods for drug delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887698A (en) * 1973-03-12 1975-06-03 Univ Leland Stanford Junior Sacs with epitopic sites on walls enclosing stable free radicals
DE2326224C3 (de) 1973-05-23 1975-11-13 Kernforschungsanlage Juelich Gmbh, 5170 Juelich Verfahren zum Abtrenne», von durch chemische oder physikalisch^ Eigenschaften ausgezeichneten ionisierten Stoffen aus einer wäßrigen Lösung
DE2326191B2 (de) 1973-05-23 1978-03-30 Hutschenreuther Ag, 8672 Selb Verfahren zum Herstellen eines Reliefdekors auf keramischen Erzeugnissen
DE2326161C2 (de) * 1973-05-23 1986-07-17 Kernforschungsanlage Jülich GmbH, 5170 Jülich Verfahren zum Aufbau oder zum Abbau von durch chemische Eigenschaften ausgezeichneten, in einer wäßrigen Lösung enthaltenen Stoffen
GB1481480A (en) * 1974-02-02 1977-07-27 Kernforschungsanlage Juelich Process and apparatus for increasing the permeability of the membrane of cells of organisms
DE2655801C2 (de) * 1976-12-09 1986-06-26 Kernforschungsanlage Jülich GmbH, 5170 Jülich Injizierbare Suspension von Membranvesikeln aus Erythrozyten und Verfahren zur Herstellung der Suspension

Also Published As

Publication number Publication date
US4289756A (en) 1981-09-15
SE445296B (sv) 1986-06-16
JPS5375385A (en) 1978-07-04
FR2374045B1 (da) 1981-06-26
FR2374045A1 (fr) 1978-07-13
GB1557649A (en) 1979-12-12
IL53596A0 (en) 1978-03-10
DE2656746C2 (de) 1986-06-26
SE7713946L (sv) 1978-06-16
CH632928A5 (de) 1982-11-15
DE2656746A1 (de) 1978-06-29

Similar Documents

Publication Publication Date Title
IL53596A (en) Biological cells externally modified for controlled release,in the spleen and/or liver,of pharmaceutically active substances comprised therein,their preparation and pharmaceutical compositions containing them
IL53594A (en) Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them
IL53595A (en) Biological cells comprising pharmaceutically active substances and particles of magnetic material,their preparation and pharmaceutical compositions containing them
MY8700198A (en) Divisible tablet having controlled and delayed release of the active substance
IL59893A0 (en) Pancreatin pellets,their preparation and pharmaceutical compositions containing them
MY8500051A (en) Novel 1-aryl-2-acylamido-3-fluoro-1-propanols, theiri preparation and pharmaceutical composition containing them
ZA805015B (en) Divisible tablet having controlled and delayed release of the active substance
IL59150A (en) N-benzyl-imidazoles,their preparation and pharmaceutical compositions containing them
DE3071385D1 (en) Antiinflammatory 5-substituted-2,3-diaryl-thiophenes, processes for their preparation and pharmaceutical compositions containing them
IL61692A (en) 2-acylaminomethyl-1,4-benzodiazepines and salts thereof,their preparation and pharmaceutical compositions containing them
IL60918A (en) 6-pyridazinones,their preparation and pharmaceutical compositions containing them
GB2058562B (en) Pharmaceutical compositions containing paracetamol and ascorbic acid
ZA884622B (en) Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance
GB2065135B (en) Pharmacologically active peptides their preparation and pharmaceutical compositions containing them
GB2065133B (en) Pharmacologically active peptides their preparation and pharmaceutical compositions containing them
DE3070184D1 (en) Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them
NZ184722A (en) Pharmaceutical compositions with controlled release of active agent in the intestinal tract
IL60307A0 (en) Alkoxybenzylpyridopyrimidines,their preparation and pharmaceutical compositions containing them
GB2065134B (en) Pharmacologically active peptides their preparation and pharmaceutical compositions containing them
JPS5626890A (en) Halovincamone derivatives* thei manufacture and medicinal composition containing it
DE2963141D1 (en) New compounds related to dilignols, compounds related to dilignols for use in the treatment of liver deseases and pharmaceutical compositions containing them
PH14606A (en) Compounds of the pregnane series with an oxygeb function in the 19-position and pharmaceutical composition containing same
IL60700A0 (en) 25-halocholest-5-ene-2 ,22-diols and esters thereof and pharmaceutical compositions containing them
IL57667A (en) 2-azaergolines and 2-aza-8-ergolines,their preparation and pharmaceutical compositions containing them
IL53552A (en) 1-piperazinopropanol esters,their preparation and pharmaceutical compositions containing them